Thermo Fisher Scientific | TMO - Marktkapitalisierung

Aktienkurs
483.61
Täglich Wechseln
3.56 0.74%
Monatlich
-4.91%
Jährlich
0.13%
Q1 Prognose
459.16




Marktkapitalisierung Veränderung Datum
Abbott USD 217.86B 15.25B 2025-12
Agilent USD 37.86B 3.64B 2025-12
Becton, Dickinson and Co. USD 55.29B 1.64B 2025-12
Bio Techne USD 9.16B 502M 2025-12
Bio-Rad Laboratories USD 6.16B 2.05B 2026-03
Boston Scientific USD 141.35B 3.31B 2025-12
Bruker USD 7.16B 2.23B 2025-12
Charles River Laboratories USD 10.02B 2.71B 2025-12
Danaher USD 161.7B 29.34B 2025-12
Dentsply International USD 2.28B 251M 2025-12
Edwards Lifesciences USD 49.47B 3.81B 2025-12
General Electric Aerospace USD 324.91B 5.91B 2025-12
Henry Schein USD 10.58B 1.61B 2026-03
Hologic USD 16.62B 1.67B 2025-12
Illumina USD 20.62B 6.53B 2025-12
Intuitive Surgical USD 200.77B 40.45B 2025-12
IQVIA Holdings USD 38.39B 6.1B 2025-12
Laboratory Of America USD 20.8B 3.03B 2025-12
Medtronic USD 105.26B 24.07B 2026-03
Mettler Toledo International USD 25.68B 2.8B 2026-03
Myriad Genetics USD 417M 158M 2026-03
Olympus JPY 1.58T 631.16B 2026-03
OraSure Technologies USD 219M 45M 2026-03
Quest Diagnostics USD 19.3B 2.01B 2025-12
Repligen USD 9.22B 1.7B 2025-12
Revvity USD 10.97B 1.21B 2025-12
Stryker USD 134.41B 6.92B 2025-12
Thermo Fisher Scientific USD 217.7B 42.4B 2025-12
Veracyte USD 3.33B 627M 2025-12
Waters USD 22.61B 5.25B 2025-12
Zimmer Biomet Holdings USD 17.82B 1.69B 2025-12